Beck Bode’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-32,998
Closed -$10.7M – 133
2024
Q1
$10.7M Buy
32,998
+2,576
+8% +$632K 2.19% 18
2023
Q4
$5.8M Buy
+30,422
New +$5.75M 1.3% 26
2023
Q3
– Sell
-4,514
Closed -$1.29M – 157
2023
Q2
$1.29M Sell
4,514
-199
-4% -$55.3K 0.31% 84
2023
Q1
$1.02M Sell
4,713
-11,983
-72% -$2.33M 0.25% 97
2022
Q4
$3.43M Sell
16,696
-717
-4% -$181K 0.77% 48
2022
Q3
$4.84M Sell
17,413
-135
-0.8% -$34.3K 1.05% 30
2022
Q2
$3.36M Buy
17,548
+10,432
+147% +$1.84M 0.71% 40
2022
Q1
$1.48M Buy
+7,116
New +$1.17M 0.33% 59

Other funds holding SWAV

Beck Bode's SWAV Position: Q2 2024 in Review

Beck Bode sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 32,998 shares — an estimated $10.7M sold.

Beck Bode first reported a position in SWAV in Q1 2022 and held it in 8 quarters. The position peaked at $10.7M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Beck Bode reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Beck Bode sold 32,998 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $10.7M.
  • Beck Bode first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Beck Bode's Shockwave Medical, Inc. Common Stock position peaked at $10.7M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Beck Bode's 13F filing for Q2 2024, filed 12 Aug 2024.